Nuvation Bio NUVB
NYSE NUVB
$5.55 -0.05 (-0.80%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nuvation Bio (NUVB) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Nuvation Bio's Net Equity Issued and Repurchased was $3.5 million in Q2 2026, up 359.4% from $762,000 a year earlier and up 285.6% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nuvation Bio's Net Equity Issued and Repurchased was $12.68 million through Jun 30, 2026, up 191.1% year-over-year; for FY2025, it was $10.11 million, up 126.8% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $4.46 million in FY2024, $375,000 in FY2023 (-60.1%), $939,000 in FY2022 (+108.7%) and $450,000 in FY2021 (-90.8%).
  • Quarterly Net Equity Issued and Repurchased has moved between $21,000 (Q1 2024) and $7.71 million (Q4 2025) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last five quarters, with growth averaging 206.8%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2025 (growth of 817.7%); the worst was Q3 2021 (a decline of 99.4%).
  • Per Business Quant data, NUVB's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $908,000 (Q1 2026), $7.71 million (Q4 2025) and $558,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Nuvation Bio 1.94 Bn 1.94 Bn - 3.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.50 Mn
Mar 31, 2026 908,000.00
Dec 31, 2025 7.71 Mn
Sep 30, 2025 558,000.00
Jun 30, 2025 762,000.00
Mar 31, 2025 1.08 Mn
Dec 31, 2024 840,000.00
Sep 30, 2024 1.67 Mn
Jun 30, 2024 1.93 Mn
Mar 31, 2024 21,000.00
Sep 30, 2023 77,000.00
Mar 31, 2023 298,000.00
Dec 31, 2022 311,000.00
Sep 30, 2022 258,000.00
Jun 30, 2022 56,000.00
Mar 31, 2022 314,000.00
Dec 31, 2021 230,000.00
Sep 30, 2021 30,000.00
API Access

Nuvation Bio Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NUVB&period=max&api_key=YOUR_API_KEY